Bosentan Therapy for Pulmonary Arterial Hypertensi
Actelion's slide show presentation to the FDA.
FDA Approves First Oral Medication for Pulmonary A
Describes the trial results and subsequent approval of Tracleer.
Pharmacodynamics and Drug Action
PDF report of an investigation into potential liver damage from bosentan use. [Acrobat Reader required]
Tracleer
Features an overview of pulmonary hypertension, prescribing information for US residents, and press releases.